Jan 10, 2024 / 07:15PM GMT
Unidentified Analyst -
Welcome, everyone. I'm Sanji Bita with JPMorgan Healthcare. And we are pleased to have with us the CEO of Lantheus, Mary Anne Heino. For logistic purposes, please reserve your questions till the end of the presentation. And with that, I will let Mary Anne take over.
Mary Anne Heino - Lantheus Holdings, Inc. - CEO & Director
Thank you. Good morning, everyone, and thank you so much for joining the Lantheus JPM presentation. As we start with the next slide, I will show you a slide that I'm sure you've seen in many other presentations. It is our policy around safe harbor statements and forward-looking information. It's available here as well as our website. So I'd appreciate if you would take a moment to look at it.
As we begin our presentation today, I'd like to share with you our vision for Lantheus, and our vision is that Lantheus will be -- is and will remain the leading radiopharmaceutical-focused company in the world. It's something that we think is very important, and it really serves our mission to find, fight and follow disease
Lantheus Holdings Inc at JPMorgan Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers